Cargando…
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
Development and progression of pancreatic cancer involves general metabolic disorder, local chronic inflammation, and multistep activation of distinct oncogenic molecular pathways. These pathologic processes result in a highly invasive and metastatic tumor phenotype that is a major obstacle to curat...
Autores principales: | Shimasaki, Takeo, Kitano, Ayako, Motoo, Yoshiharu, Minamoto, Toshinari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516047/ https://www.ncbi.nlm.nih.gov/pubmed/23230392 http://dx.doi.org/10.4103/1477-3163.100866 |
Ejemplares similares
-
Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
por: Kitano, Ayako, et al.
Publicado: (2013) -
Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy
por: Domoto, Takahiro, et al.
Publicado: (2016) -
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020) -
Glycogen synthase kinase‐3β participates in acquired resistance to gemcitabine in pancreatic cancer
por: Uehara, Masahiro, et al.
Publicado: (2020) -
Metabolic Disorder, Inflammation, and Deregulated Molecular Pathways Converging in Pancreatic Cancer Development: Implications for New Therapeutic Strategies
por: Motoo, Yoshiharu, et al.
Publicado: (2011)